Literature DB >> 19339047

Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements.

Olga Tsigkou1, Julian R Jones, Julia M Polak, Molly M Stevens.   

Abstract

Bioactive glasses bond strongly to bone in vivo and their ionic dissolution products have previously been shown to have stimulatory properties on adult and fetal osteoblasts and to induce the differentiation of embryonic stem cells towards the osteoblastic lineage in vitro. In the present study, the effect of 45S5 Bioglass conditioned medium with two different Si concentrations (15 microg/ml (BGCM/15) and 20 microg/ml (BGCM/20)) on human fetal osteoblast growth, differentiation and extracellular matrix production and mineralization was investigated. In the first instance, primary fetal osteoblasts were examined for the osteoblast phenotypic markers alkaline phosphatase (ALP), collagen type I (Col I) and OB Cadherin (Cadherin 11) (OB Cad) as well as for the mesenchymal stem cell markers CD105 and CD166. At passage 0 more than 50% of the population was positive for Col I and ALP, but at passage 2, the proportion of cells expressing ALP increased. In addition at passage 0 more than 50% of the fetal osteoblasts expressed the mesenchymal stem cell surface markers CD105 and CD166. Treatment with BGCM/15 and BGCM/20 in the absence of osteogenic supplements increased the gene expression of the bone extracellular matrix proteins alkaline phosphatase, osteonectin and bone sialoprotein as determined by quantitative real time reverse transcriptase-polymerase chain reaction (rt RT-PCR) analysis. Extracellular matrix production was also enhanced in the absence of osteogenic supplements by the 45S5 Bioglass conditioned medium as demonstrated by ALP enzymatic activity, osteocalcin and Col I protein synthesis. Furthermore, BGCM/15 and BGCM/20 significantly enhanced the formation of mineralized nodules, based on alizarin red histochemical staining, without necessitating the addition of beta-glycerophosphate, l-ascorbate-2-phosphate or dexamethasone (commonly used osteogenic supplements).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339047     DOI: 10.1016/j.biomaterials.2009.03.019

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  36 in total

1.  A novel bioactive vitroceramic presents similar biological responses as autogenous bone grafts.

Authors:  Mariza Akemi Matsumoto; Gustavo Caviquioli; Claudia Cristina Biguetti; Leandro de Andrade Holgado; Patrícia Pinto Saraiva; Ana Claudia Muniz Rennó; Roberto Yoshio Kawakami
Journal:  J Mater Sci Mater Med       Date:  2012-03-18       Impact factor: 3.896

2.  Sparse feature selection methods identify unexpected global cellular response to strontium-containing materials.

Authors:  Hélène Autefage; Eileen Gentleman; Elena Littmann; Martin A B Hedegaard; Thomas Von Erlach; Matthew O'Donnell; Frank R Burden; David A Winkler; Molly M Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

3.  "In vitro" behaviour of adult mesenchymal stem cells of human bone marrow origin seeded on a novel bioactive ceramics in the Ca2SiO4-Ca 3(PO4)2 system.

Authors:  Luis Meseguer-Olmo; Salvador Aznar-Cervantes; Patricia Mazón; Piedad N De Aza
Journal:  J Mater Sci Mater Med       Date:  2012-08-19       Impact factor: 3.896

Review 4.  Osseointegration of osteoporotic bone implants: Role of stem cells, Silica and Strontium - A concise review.

Authors:  Sunitha Chandran; Annie John
Journal:  J Clin Orthop Trauma       Date:  2018-08-04

5.  Role of phase separation on the biological performance of 45S5 Bioglass®.

Authors:  Tia J Kowal; Roman Golovchak; Tanuj Chokshi; Joseph Harms; Ukrit Thamma; Himanshu Jain; Matthias M Falk
Journal:  J Mater Sci Mater Med       Date:  2017-09-13       Impact factor: 3.896

6.  Heterogeneous dental follicle cells and the regeneration of complex periodontal tissues.

Authors:  Weihua Guo; Lei Chen; Kun Gong; Bofu Ding; Yinzhong Duan; Yan Jin
Journal:  Tissue Eng Part A       Date:  2012-01-26       Impact factor: 3.845

7.  Bioactive glass 13-93 as a subchondral substrate for tissue-engineered osteochondral constructs: a pilot study.

Authors:  Prakash Jayabalan; Andrea R Tan; Mohammed N Rahaman; B Sonny Bal; Clark T Hung; James L Cook
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

8.  Bone scaffold architecture modulates the development of mineralized bone matrix by human embryonic stem cells.

Authors:  Ivan Marcos-Campos; Darja Marolt; Petros Petridis; Sarindr Bhumiratana; Daniel Schmidt; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2012-08-16       Impact factor: 12.479

9.  The effect of mesoporous bioglass on osteogenesis and adipogenesis of osteoporotic BMSCs.

Authors:  Tao Wu; Ning Cheng; Chun Xu; Wei Sun; Chengzhong Yu; Bin Shi
Journal:  J Biomed Mater Res A       Date:  2016-08-05       Impact factor: 4.396

10.  Chitosan/poly(DL,lactide-co-glycolide) scaffolds for tissue engineering.

Authors:  S A Martel-Estrada; I Olivas-Armendáriz; C A Martínez-Pérez; T Hernández; E I Acosta-Gómez; J G Chacón-Nava; F Jiménez-Vega; P E García-Casillas
Journal:  J Mater Sci Mater Med       Date:  2012-09-09       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.